In summary, even though AGN193109 effects in these experiments were relatively small, probably reflecting low atRA concentrations in the media, our data show that atRA promotes, and the pan-RAR antagonist counteracts, stem/progenitor properties in a manner related to the expression of EVI1 also in primary AML samples. This evidence concerns the gene RUNX1 and acute myeloid leukemia.